Annette Ekblond

Medicine & Life Sciences

1. Mesenchymal Stem Cells 100%
2. Stromal Cells 95%
3. Cell- and Tissue-Based Therapy 37%
4. Placebos 28%
5. Heart Failure 28%
6. Stroke Volume 25%
7. Adipose Tissue 25%
8. Myocardial Ischemia 25%
9. Injections 22%
10. Safety 19%
11. Stem Cells 16%
12. Vascular Endothelial Growth Factor A 16%
13. Therapeutics 15%
14. Bone Marrow 14%
15. Xerostomia 13%
16. Cryopreservation 13%
17. Cardiology 13%
18. Tissue Donors 12%
19. Blood Platelets 12%
20. Alginates 11%
21. 64Cu-DOTATATE 11%
22. Hydrogels 11%
23. Cardiomyopathies 10%
24. In Vitro Techniques 10%
25. Serum 9%
26. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 9%
27. Bioreactors 9%
28. ferric oxide 9%
29. Multicenter Studies 8%
30. Phenotype 8%
31. Cattle 8%
32. Radiation 8%
33. ferumoxtran-10 8%
34. Monocytes 7%
35. human VEGFA protein 7%
36. Crowding 7%
37. Coculture Techniques 6%
38. Lymphocytes 6%
39. Blood Cells 6%
40. Head and Neck Neoplasms 6%
41. Trans-Activators 6%
42. Dry Eye Syndromes 6%
43. Nanoparticles 6%
44. Clinical Trials 6%
45. Exercise 5%
46. Phytohemagglutinins 5%
47. Mitogens 5%
48. Dilated Cardiomyopathy 5%
49. Quality Control 5%
50. Genes 5%